Micronutrients decrease incidence of common infections in type 2 diabetic outpatients
Yinghua Liu, Hongjiang Jing, Jin Wang, Rongxin Zhang, Yuehong Zhang, Yong Zhang, Qing Xu, Xiaoming Yu, Changyong Xue, Yinghua Liu, Hongjiang Jing, Jin Wang, Rongxin Zhang, Yuehong Zhang, Yong Zhang, Qing Xu, Xiaoming Yu, Changyong Xue
Abstract
A randomized, double-blind, placebo-controlled trial was carried out to investigate the effects of micronutrients supplementation on immunity and the incidence of common infections in type 2 diabetic outpatients. A total of 196 type 2 diabetic outpatients were randomized to receive tablets of micronutrients (n=97) or placebo (n=99) for 6 months. Individualized dietary energy intake and daily physical activity were recommended. Anthropometric measurements, blood biochemical variables and the incidence of common infections were measured at baseline and at 6 months. Data on diet, exercise and infection (upper respiratory tract infection, skin infection, urinary and genital tract infections, other infections) were recorded 1 month before the study and every month during the study. Blood concentrations of total protein, iron (Fe), folic acid and hemoglobin increased and unsaturated iron-binding capacity(UIBC) levels were decreased in the micronutrients supplementation group compared to the placebo group at 6 months. Moreover, at 6 months, compared to the placebo group, the blood concentrations of IgE, CD4+, CD4+/CD8+, WBC, lymphocyte counts, basophilic leukocyte increased and CD8+ count decreased in the supplementation group, and the levels of IgA, IgM, IgG and complements C3 and C4 did not differ. The incidence of upper respiratory infection, whitlow, dermapostasis, vaginitis, urinary tract infection, gingivitis and dental ulcer were lower and body temperature and duration of fever greatly improved in the supplementation than the placebo group. These data indicated that supplementation of micronutrients might increase immune function and reduce the incidence of common infections in type 2 diabetic outpatients.
Source: PubMed
Nadchodzące badania kliniczne
-
Kanglin Biotechnology (Hangzhou) Co., Ltd.Jeszcze nie rekrutacjaChoroba Parkinsona (PD) | Advanced Primary PDChiny
-
Carilion ClinicRekrutacyjnyPrzewlekły krwiak podtwardówkowy | NawracającyStany Zjednoczone
-
Mahidol UniversityJeszcze nie rekrutacjaRak piersi | Rak przewodowy in situ
-
Biosensors Europe SAJeszcze nie rekrutacjaNSTEMI | Niestabilna dławica piersiowa (UA) | Dławica piersiowa (stabilna)Zjednoczone Królestwo
-
CooperVision International Limited (CVIL)Jeszcze nie rekrutacja
-
Shanghai Yueyang Integrated Medicine HospitalRekrutacyjnySarkopenia u osób starszychChiny
-
University of Management and Technology LahoreJeszcze nie rekrutacjaFarward Head PosturePakistan
-
China National Center for Cardiovascular DiseasesJeszcze nie rekrutacjaBalon powlekany lekiem | USG wewnątrznaczyniowe | De Novo Large Coronary VesselChiny
-
Korea University Anam HospitalJeszcze nie rekrutacjaAF - Migotanie przedsionkówKorea Południowa
-
Jijun WangRekrutacyjny
-
DiproBio (Shanghai) Co., Ltd.Jeszcze nie rekrutacjaZdrowie psychiczne | Stres psychicznyChiny
-
Emory UniversityJeszcze nie rekrutacjaZwiązane z ciążą | Hypertensive Disorder of Pregnancy (HDP)Stany Zjednoczone